FindTrial
Sign In

Research for lncRNAs and miRNAs used in atherosclerosis as clinical diagnosis biomarkers

Research for lncRNAs and miRNAs used in atherosclerosis as clinical diagnosis biomarkers

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-DDT-14004368
Enrollment
Unknown
Registered
2014-03-11
Start date
2014-04-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

atherosclerosis

Interventions

Gold Standard:
Index test:

Sponsors

Nanfang Hospital, Southern Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Samples from patients who were diagnosed with atherosclerosis according to The People's Republic of China health department diagnostic criteria of atherosclerosis; 2. Subjects are aged 18-80,Gender Not Required; 3. Written informed condent was obtained from all subjects.

Exclusion criteria

Exclusion criteria: 1. Inability to comply with study-related procedures; 2. Any other clinical trials within 30 days Pre-vaccination; 3. Female patients who are pregnant or breastfeeding.

Design outcomes

Primary

MeasureTime frame
lncRNA;—

Countries

China

Contacts

Public ContactQian Wang

Nanfang Hospital, Southern Medical University

wangqian@fimmu.com+86 020-61641007

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026